GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » bioXXmed AG (XTER:T5O) » Definitions » FCF Margin %

bioXXmed AG (XTER:T5O) FCF Margin % : -211,808.33% (As of Jun. 2023)


View and export this data going back to 2006. Start your Free Trial

What is bioXXmed AG FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. bioXXmed AG's Free Cash Flow for the six months ended in Jun. 2023 was €-25.42 Mil. bioXXmed AG's Revenue for the six months ended in Jun. 2023 was €0.01 Mil. Therefore, bioXXmed AG's FCF Margin % for the quarter that ended in Jun. 2023 was -211,808.33%.

As of today, bioXXmed AG's current FCF Yield % is 2,582.81%.

The historical rank and industry rank for bioXXmed AG's FCF Margin % or its related term are showing as below:

XTER:T5O' s FCF Margin % Range Over the Past 10 Years
Min: -127200   Med: -3174.72   Max: 329050
Current: 329050


During the past 13 years, the highest FCF Margin % of bioXXmed AG was 329050.00%. The lowest was -127200.00%. And the median was -3174.72%.

XTER:T5O's FCF Margin % is ranked better than
99.9% of 1047 companies
in the Biotechnology industry
Industry Median: -145.04 vs XTER:T5O: 329050.00


bioXXmed AG FCF Margin % Historical Data

The historical data trend for bioXXmed AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

bioXXmed AG FCF Margin % Chart

bioXXmed AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -127,200.00 -2,569.44 -4,613.89 -3,780.00 -7,625.00

bioXXmed AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15,700.00 -2,332.50 -2,303,525.00 1,140,337.50 -211,808.33

Competitive Comparison of bioXXmed AG's FCF Margin %

For the Biotechnology subindustry, bioXXmed AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


bioXXmed AG's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, bioXXmed AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where bioXXmed AG's FCF Margin % falls into.



bioXXmed AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

bioXXmed AG's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-0.915/0.012
=-7,625.00 %

bioXXmed AG's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-25.417/0.012
=-211,808.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


bioXXmed AG FCF Margin % Related Terms

Thank you for viewing the detailed overview of bioXXmed AG's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


bioXXmed AG (XTER:T5O) Business Description

Traded in Other Exchanges
Address
Riedstrasse 2, Darmstadt, HE, DEU, 64295
bioXXmed AG is an investment and holding company in the technology sector. It originated from CytoTools GmbH, a successful German technology enterprise from the pharmaceuticals and medical products field.

bioXXmed AG (XTER:T5O) Headlines

No Headlines